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Abstract
Background: Several different genetic and environmental factors have been identified
as independent risk factors for bladder cancer in population-based studies. Recent
studies have turned to understanding the role of gene-gene and gene-environment
interactions in determining risk. We previously developed the bioinformatics framework
of statistical epistasis networks (SEN) to characterize the global structure of interacting
genetic factors associated with a particular disease or clinical outcome. By applying SEN
to a population-based study of bladder cancer among Caucasians in New Hampshire,
we were able to identify a set of connected genetic factors with strong and significant
interaction effects on bladder cancer susceptibility.
Findings: To support our statistical findings using networks, in the present study, we
performed pathway enrichment analyses on the set of genes identified using SEN, and
found that they are associated with the carcinogen benzo[a]pyrene, a component of
tobacco smoke. We further carried out an mRNA expression microarray experiment to
validate statistical genetic interactions, and to determine if the set of genes identified in
the SEN were differentially expressed in a normal bladder cell line and a bladder cancer
cell line in the presence or absence of benzo[a]pyrene. Significant nonrandom sets
of genes from the SEN were found to be differentially expressed in response to
benzo[a]pyrene in both the normal bladder cells and the bladder cancer cells. In addition,
the patterns of gene expression were significantly different between these two cell types.
Conclusions: The enrichment analyses and the gene expression microarray results
support the idea that SEN analysis of bladder in population-based studies is able to
identify biologically meaningful statistical patterns. These results bring us a step closer
to a systems genetic approach to understanding cancer susceptibility that integrates
population and laboratory-based studies.
Keywords: Epistasis, Gene-gene interactions, Statistical epistasis networks,
Benzo[a]pyrene, Gene-drug association, Bladder cancer
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Findings
Introduction

Tobacco consumption has been implicated as the most relevant risk factor for the
development of bladder cancer. Among various carcinogens identified in tobacco
smoke, the polycyclic aromatic hydrocarbons (PAHs) are well characterized and their
risk associations with bladder cancer are well studied [1-4]. In addition to these strong
environmental risk factors, recent genome-wide association studies have identified
several highly significant genetic factors with small effects [5,6]. Some of these have
been shown to modify the effects of smoking on risk of bladder cancer [7].
Most existing genetic association studies have focused on the independent effects of
individual genes. That is, they have by design ignored the context of human ecology
and the extensive variability in the human genome. As a result, much of the heritability
of common human diseases such as bladder cancer remains unexplained. Multiple
approaches have been proposed to account for this missing heritability including
sequencing to identify causative rare variants and advanced analytical strategies to
characterize those genetic effects that are context-dependent [8]. The characterization
of gene-gene interaction effects, i.e. epistasis, provides a promising research avenue to
understand the complex genetic architecture underlying common human diseases in
population-based studies [9-11]. Previously, we developed a network-based framework,
statistical epistasis networks (SEN), to characterize the global epistatic interaction space
of bladder cancer [12,13]. SEN were able to identify a large set of interacting singlenucleotide polymorphisms (SNPs) that had strong associations with bladder cancer. In
addition, these SNPs were organized in the form of a connected network structure that
was highly significant and nonrandom compared to the null distribution of networks
generated using permutation tests.
The goal of the present study was to determine whether the SEN identified for bladder cancer have any biological relevance in the context of the most prevalent risk
factor. Because the majority of bladder cancer cases in the United States can be attributed to tobacco exposure, we hypothesized that many of the SEN genes would have a
biological role related to biological response to PAH exposure. Here, we applied pathway enrichment analysis of the bladder cancer SEN and found that it is enriched for
genes that have strong associations with benzo[a]pyrene. We carried out a gene expression microarray experiment in cell lines from normal bladder and bladder cancer cells
treated with and without benzo[a]pyrene. The goal of this experiment was to provide a
functional genomics annotation of the SEN.

Methods and results

In the framework of SEN [12], first we exhaustively measured the non-additive statistical interactions among all pairs of SNPs in a large population-based bladder cancer
case–control dataset [14]. The information theoretic measurement information gain
was used to quantify the epistatic interaction between two SNPs associated with
bladder cancer [15-17]. The information gain measure was able to separate the pure
synergistic interaction effect from the additive main effects of a pair of genetic attributes, and thus to characterize their statistical epistasis associated with a particular
disease status or phenotype. Network properties, including network size, global
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network connectivity, and degree distribution, were analyzed to systematically derive
a pairwise interaction strength threshold to construct an interaction network that
had significantly distinct structures compared to null networks built from permutation testing [12]. This network had a sizable largest connected component including
39 SNPs from 29 cancer susceptibility genes (Table 1), which were absent in any of
the 1000 null networks using permuted data. We speculated that these identified 29
genes captured an important aspect of the underlying complex genetic structure of
bladder cancer [12].
To further validate the effectiveness of our population-based SEN methodology at
capturing meaningful biology in our bladder cancer epistatic interaction network, we
performed functional enrichment analyses on those 29 genes using ToppGene [18].
ToppGene detects functional enrichment of a given gene list based on ontologies,
Table 1 The 29 genes identified in our previous genetic interaction study on bladder
cancer using SEN
Symbol

Entrez Gene ID

Description

AHRR

57491

Aryl-hydrocarbon receptor repressor

AKR1C3

8644

Aldo-keto reductase family 1, member C3

AXIN2

8313

Axin2

BCL6

604

B-cell CLL/lymphoma 6

BIRC3

330

Baculoviral IAP repeat containing 3

CARD15

64127

Nucleotide-binding oligomerization domain containing 2

CAT

847

Catalase

CCL5

6352

Chemokine (C-C motif) ligand 5

CCNH

902

Cyclin H

FTHFD

10840

Aldehyde dehydrogenase 1 family, member L1

GATA3

2625

GATA binding protein 3

GSTM3

2947

Glutathione S-transferase mu 3 (brain)

HSD17B4

3295

Hydroxysteroid (17-beta) dehydrogenase 4

IGF1R

3480

Insulin-like growth factor 1 receptor

IL1A

3552

Interleukin 1, alpha

INSR

3643

Insulin receptor

MASP1

5648

Mannan-binding lectin serine peptidase 1 (C4/C2 activating
component of Ra-reactive factor)

MBD2

8932

Methyl-CpG binding domain protein 2

MMP1

4312

Matrix metallopeptidase 1 (interstitial collagenase)

MYBL2

4605

V-myb myeloblastosis viral oncogene homolog (avian)-like 2

NEDD5

4735

Septin 2

OPRM1

4988

Opioid receptor, mu 1

PARP4

143

Poly (ADP-ribose) polymerase family, member 4

PGR

5241

Progesterone receptor

PIM1

5292

Pim-1 oncogene

RERG

85004

RAS-like, estrogen-regulated, growth inhibitor

TNKS

8658

Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase

TP53I3

9540

Tumor protein p53 inducible protein 3

XPC

7508

Xeroderma pigmentosum, complementation group C
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pathways, phenotypes, drug-gene association, etc. All statistical results were corrected
for multiple testing using the Bonferroni method. For our list of 29 genes, the most
significant biological process from the Gene Ontology analysis was response to organic
cyclic compound (p = 1.27*10-5). Figure 1 summarizes all 39 significant biological
processes. In addition, the most significant chemical from the drug-gene analysis was
benzo[a]pyrene (p = 2.90*10-5). Figure 2 summarizes all 34 significant drug-gene
categories. These enrichment results indicate that our SEN successfully identified interacting genes that are mostly targeted and regulated by the carcinogen benzo[a]pyrene.
Next, we performed a gene expression microarray experiment by exposing both
normal bladder cells and bladder cancer cells to benzo[a]pyrene. Four plates each of
the normal urothelial cell line UROtsa and the tumorigenic cell line J82 with and
without the treatment of 10 uM benzo[a]pyrene, were cultured. mRNAs were purified
and transcription levels were measured using the HumanHT-12 v3 Expression BeadChip
(Illumina, Inc., San Diego, CA). There were 47,230 probes on the array of which 29,785
were kept after filtering for detectable probes (detection p-value ≤ 0.05). A quantile
normalization method was applied to normalize the data [19]. To test for genes that were
differentially expressed in cell lines with and without benzo[a]pyrene treatment, we used a

Figure 1 ToppGene enrichment analysis on the GO biological process. Terms were considered
significant when their significance p < 0.05 (after Bonferroni multiple-testing correction). Bars show the
gene counts from our list of 29 genes, and lines show the enrichment significance levels. Terms (y-axis)
are ranked based on their p-values.
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Figure 2 ToppGene enrichment analysis on the drug-gene association. Significant terms were chosen
with a Bonferroni multiple-testing corrected significance level p < 0.05. Bars show the gene counts from our
list of 29 genes, and lines show their enrichment p -values.

random variance t-test as described by Wright et al. [20]. Genes with a parametric
p ≤ 0.05 were considered differentially expressed.
Out of the 29 genes identified in our SEN, 26 had detectable probes on the microarray. Their differential expression patterns are shown in Figure 3. Of these, there were
16 genes that had lower expression levels in the J82 untreated bladder cancer cells
compared to the UROtsa untreated cells. When comparing J82 cells with and without
the treatment, six genes were identified as differentially expressed. Out of these six genes,
BIRC3, AKR1C3, and BCL6 were up-regulated with the treatment of benzo[a]pyrene,
whereas IL1A, MBD2, and AXIN2 were down-regulated. For the UROtsa cell line with
and without the toxicant treatment, six genes were identified as differentially expressed.
Among them, AHRR and IL1A were up-regulated, whereas NEDD5, INSR, CAT, and
BCL6 were down-regulated with the presence of benzo[a]pyrene. It is interesting to note
that, although IL1A was differentially expressed in both cell lines with and without the
toxicant treatment, the direction of the change was opposite.
We then annotated the genes with significantly differential expressions, either
up-regulated or down-regulated, in our SEN (Figure 4). We first transformed the
original SNP-SNP interaction network into a gene-gene interaction network by setting
each vertex as a gene and connecting two genes if there existed at least one pair of
SNPs, each from one of the two genes, that had a significant and strong pairwise interaction in the original SEN. Genes that were differentially expressed in the normal
UROtsa cells with and without the toxicant treatment are shown in blue color in
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Figure 3 Gene expression levels in the four groups of samples of our network genes. The green
color indicates up-regulation, and red color indicates down-regulation. Genes are clustered based on their
expression patterns across all four groups.

Figure 4. Pink colored vertices represent genes that were differentially expressed in the
tumorigenic J82 cells with and without the toxicant treatment. Also note that two
genes, IL1A and BCL6, were identified differentially expressed in both the normal and
the cancer cells. The IL1A gene encodes for interleukin 1 alpha, a member of the
interleukin 1 cytokine family. This cytokine is produced by monocytes and macrophages
as a proprotein, which is proteolytically processed and released in response to cell injury and thus induces apoptosis. IL1A was up-regulated in the normal UROtsa cell
but down-regulated in the tumorigenic J82 cells in response to the treatment of
benzo[a]pyrene. Since a major function of IL1A is to induce apoptosis, a mechanism
for programmed killing of potentially harmful cells, the identification of IL1A both in
the SEN and in the differential gene expression experiment suggests its potential role in
interacting with the carcinogen and the development of bladder cancer. Likewise, the
Aryl-Hydrocarbon Receptor Repressor (AHRR) responded differentially to benzo[a]pyrene
treatment by cell line. Expression levels are increased by tobacco smoke exposure
by a mechanism involving less DNA methylation [21]. We observed increased AHRR
expression in the normal bladder epithelial cells, as expected, however the opposite
relationship in the cancer cell line. To provide further validation for our results, we
used the ten differentially expressed SEN genes (Figure 4) for another enrichment
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Figure 4 Gene-gene interaction network annotated with differentially expressed genes in response
to benzo[a]pyrene. Each vertex represents a gene and two genes are connected by an edge if they have
detected significant and strong statistical epistatic interactions through their underlying gene-coding SNPs.
Vertices are labeled with gene symbols and colored with differential expressions in the normal UROtsa cells
(blue) and the cancer J82 cells (pink).

analysis using ToppGene, and a strong drug association with benzo[a]pyrene was
detected (p = 3.733*10-3).
It is interesting to observe that the normal UROtsa cell and the tumorigenic J82
cells only had two differentially expressed genes in common. The SEN was derived
from a population-based case–control study. Genes in the network were those that
contained SNPs associated with bladder cancer risk. The fact that their expression
levels changed differently in normal and tumorigenic cells supports a biological role
for these genes in response to tobacco, that potentially the cells to have greater
susceptibility to transformation or carcinogenic progression. The differential responses to benzo[a]pyrene in the normal and cancer cells indicate the possible
contribution of interactions between genetic factors and the tobacco carcinogen to
bladder cancer risk.
Conclusion

In this study, we used functional genomics data to validate genetic interaction network that was constructed purely based on statistical analysis. We performed an enrichment analysis on a set of genes previously identified by our SEN methodology
that had strong and significant epistatic interactions associated with bladder cancer.
We tested the hypothesis that these susceptibility genes would be related to tobacco
response, since this is the major bladder carcinogen. The enrichment analysis results suggested our network had more genes that respond to a tabacco carcinogen
benzo[a]pyrene than would be expected by chance. We then carried out a microarray
experiment culturing normal bladder and bladder cancer cells in the presence or
absence of benzo[a]pyrene. These results showed that there were more genes in our
SEN that respond to benzo[a]pyrene than would be expected by chance given the
size of the network. These gene set enrichment and functional genomics annotation
analysis results suggest that the SEN methodology may be able to capture biological
effects at the heart of the interplay between environmental factors such as smoking
and the complex gene-gene interactions that likely influence risk of bladder cancer.
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Although not functional proof, this study demonstrates how integrating populationbased statistical results with cellular experiments can assist with interpretation
of associations to provide a systems genetics approach to understanding cancer
susceptibility.
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GO: Gene Ontology.
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